First U.S. Rules for Generic Biotechnology Drugs Set Out in Draft Proposal – Bloomberg
By Dr. Matthew Watson
 USA TODAY | First U.S. Rules for Generic Biotechnology Drugs Set Out in Draft Proposal Bloomberg US regulators proposed guidelines for approving the first lower-cost copies of biologic drugs derived from living cells in a move that will help cut national health spending by an estimated $25 billion over a decade. The Food and Drug Administration ... Biotechnology Drug Copies to Get New FDA RulesThirdAge US Releases Draft Guidelines for Generic Biotechnology DrugsBusinessWeek FDA sets draft rules for biotech drug copiesFox News MarketWatch (press release) -NASDAQ all 245 news articles » |
Source:
http://news.google.com/news?q=biotechnology&output=rss
Uncategorized
Comments Off on First U.S. Rules for Generic Biotechnology Drugs Set Out in Draft Proposal – Bloomberg |
February 12th, 2012
This author published 5852 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research